Parabilis Medicines, Inc. (PBLS)
Deferred Revenue
$13.54M
Quarterly · Period ending: · USD

PBLS Deferred Revenue
What is deferred revenue?
Revenue received but not yet earned.
PBLS deferred revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 0 | |
| 0 |
Frequently asked questions: PBLS deferred revenue
What is Parabilis Medicines, Inc. (PBLS)'s current deferred revenue?
Parabilis Medicines, Inc. (PBLS)'s latest reported deferred revenue (Quarterly) is $13.54M as of Sep 30, 2026. Revenue received but not yet earned.
How much historical deferred revenue data is available for PBLS?
Stock Alarm Pro provides 2 dated annual fiscal periods observations for Parabilis Medicines, Inc. (PBLS)'s deferred revenue, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare PBLS's deferred revenue to peers or set an alert?
You can open PBLS's deferred revenue in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on PBLS delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance